Stock & Company Details
Immunovant Inc $IMVT
Price:
N/A
N/A
207M
$7.8B
52 Week High:
N/A
10 Day Average Volume:
N/A
-13.40
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
IMVT technical indicators
Latest Immunovant Inc (IMVT) indicator readings as of 2026-09-18.
IMVT's 14-day RSI is 36.1, in neutral territory. At $36.95 it is trading 18.5% above its 200-day moving average of $31.18, and below its 50-day average of $40.16. Price sits in the middle of its Bollinger Bands ($34.74 to $45.04). ADX reads 18.7, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
mmunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.
Finance Bot
Ask your questions
Start by typing a question below.
